It has been reported that activation of death receptors by specific monoclonal antibodies induces programmed cell death in tumor cells.32, 33, 34 We have previously demonstrated that MMC induces FasL-mediated bystander killing in hepatocellular carcinoma cells.6 However, the use of MMC in cervical cancer shows inadequate effect owing to its limited efficacy and failing to promote bystander killing. Here, FASLG is linked to cervical cancer.